Sectors

EOLS
Evolus, Inc.
8.99
2 x 4.47
2 x 7.82
bid
ask
+
0.11
1.30%
02:10 PM
timesize
Ytd35.26%
1y17.89%
8.75
day range
9.05
3.86
52 week range
9.12
Open8.85Prev Close8.88Low8.75High9.05Mkt Cap594.12M
Vol435.91KAvg Vol894.67KEPS-0.53P/EN/AForward P/E54.20
Beta1.35Short Ratio7.38Inst. Own80.22%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-0450-d Avg7.04200-d Avg6.011yr Est23.43

EOLS News

Wall Street Analysts Think Evolus (EOLS) Could Surge 77.68%: Read This Before Placing a Bet
zacks.com
Wall Street Analysts Think Evolus (EOLS) Could Surge 77.68%: Read This Before Placing a Bet

The mean of analysts' price targets for Evolus (EOLS) points to a 77.7% upside in the stock. While t

benzinga.com
HC Wainwright & Co. Reiterates Buy on Evolus, Maintains $13 Price Target

HC Wainwright & Co. analyst Douglas Tsao reiterates Evolus (NASDAQ:EOLS) with a Buy and maint

Evolus (NASDAQ:EOLS) Reaches New 52-Week High  – Time to Buy?
defenseworld.net
Evolus (NASDAQ:EOLS) Reaches New 52-Week High – Time to Buy?

Evolus, Inc. (NASDAQ: EOLS - Get Free Report)'s stock price reached a new 52-week high during mid-da

Assenagon Asset Management S.A. Grows Stock Holdings in Evolus, Inc. $EOLS
defenseworld.net
Assenagon Asset Management S.A. Grows Stock Holdings in Evolus, Inc. $EOLS

Assenagon Asset Management S.A. lifted its holdings in Evolus, Inc. (NASDAQ: EOLS) by 51.8% in the u

Wall Street Analysts Believe Evolus (EOLS) Could Rally 106.08%: Here's is How to Trade
zacks.com
Wall Street Analysts Believe Evolus (EOLS) Could Rally 106.08%: Here's is How to Trade

The average of price targets set by Wall Street analysts indicates a potential upside of 106.1% in E

Evolus: The Injectable Platform Is Becoming The Real Moat
seekingalpha.com
Evolus: The Injectable Platform Is Becoming The Real Moat

Evolus is evolving into a multi-product aesthetics platform, leveraging its distribution network and

Evolus, Inc. (EOLS) Q2 2026 Earnings Call Transcript
seekingalpha.com
Evolus, Inc. (EOLS) Q2 2026 Earnings Call Transcript

Evolus, Inc. (EOLS) Q2 2026 Earnings Call Transcript

Evolus, Inc. (EOLS) Reports Break-Even Earnings for Q2
zacks.com
Evolus, Inc. (EOLS) Reports Break-Even Earnings for Q2

Evolus, Inc. (EOLS) reported break-even quarterly earnings per share versus the Zacks Consensus Esti

Evolus Q2 Earnings Call Highlights
marketbeat.com
Evolus Q2 Earnings Call Highlights

Evolus NASDAQ: EOLS reported second-quarter revenue growth of 21% and raised the lower end of its fu

benzinga.com
Evolus Q2 EPS $(0.12), Sales $84.084M Beat $81.603M Estimate

Evolus (NASDAQ:EOLS) reported quarterly losses of $(0.12) per share which beat the analyst consensus

benzinga.com
Evolus Raises FY2026 Sales Guidance from $327.000M-$337.000M to $330.000M-$337.000M vs $330.445M Est

Evolus (NASDAQ:EOLS) raises FY2026 sales outlook from $327.000 million-$337.000 million to $330.000

Evolus Reports Strong Second Quarter 2026 Financial Results; Delivers Third Consecutive Quarter of Positive Adjusted EBITDA and Raises Full-Year 2026 Financial Outlook
businesswire.com
Evolus Reports Strong Second Quarter 2026 Financial Results; Delivers Third Consecutive Quarter of P

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a global performance beauty com

Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, and New Zealand
gurufocus.com
Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, an

[url="]Evolus, Inc.[/url] (NASDAQ: EOLS), a global performance beauty company with a focus on buildi

Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, and New Zealand
businesswire.com
Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, an

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a global performance beauty com

Evolus to Report Second Quarter Financial Results on August 5, 2026
businesswire.com
Evolus to Report Second Quarter Financial Results on August 5, 2026

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company wi

Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company wi

benzinga.com
Evolus Enters Into Exclusive Licensing And Distribution Agreement With IBSA To Develop And Commercia

Evolus, Inc. (NASDAQ:EOLS), a global performance beauty company with a focus on building an aestheti

Evolus Announces Partnership with IBSA to Develop and Commercialize Market-Leading Profhilo® in the United States, Expanding Its Injectable Portfolio into Skin Quality
businesswire.com
Evolus Announces Partnership with IBSA to Develop and Commercialize Market-Leading Profhilo® in the

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a global performance beauty com

benzinga.com
Evolus Files Prospectus To Offer Up To $250M Of Securities

https://www.sec.gov/Archives/edgar/data/1570562/000157056226000071/evoluss-32026.htm

Evolus to Participate in The Jefferies Global Healthcare Conference
businesswire.com
Evolus to Participate in The Jefferies Global Healthcare Conference

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company wi

Evolus Announces Commercial Launch of Estyme® Injectable Hyaluronic Acid Gels in Europe
businesswire.com
Evolus Announces Commercial Launch of Estyme® Injectable Hyaluronic Acid Gels in Europe

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a global performance beauty com

Evolus, Inc. (EOLS) Q1 2026 Earnings Call Transcript
seekingalpha.com
Evolus, Inc. (EOLS) Q1 2026 Earnings Call Transcript

Evolus, Inc. (EOLS) Q1 2026 Earnings Call Transcript

Evolus, Inc. (EOLS) Reports Q1 Loss, Tops Revenue Estimates
zacks.com
Evolus, Inc. (EOLS) Reports Q1 Loss, Tops Revenue Estimates

Evolus, Inc. (EOLS) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Esti

benzinga.com
Evolus Affirms FY2026 Sales Guidance of $327.000M-$337.000M vs $330.020M Est

Evolus (NASDAQ:EOLS) affirms FY2026 sales outlook from $327.000 million-$337.000 million to $327.000

benzinga.com
Evolus Q1 Adj. EPS $(0.16) Misses $(0.13) Estimate, Sales $73.137M Beat $72.288M Estimate

Evolus (NASDAQ:EOLS) reported quarterly losses of $(0.16) per share which missed the analyst consens

Evolus Reports First Quarter 2026 Financial Results; Company Delivers Second Consecutive Quarter of Positive Adjusted EBITDA and Reaffirms Full-Year Outlook
businesswire.com
Evolus Reports First Quarter 2026 Financial Results; Company Delivers Second Consecutive Quarter of

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a global performance beauty com

Norwegian Cruise Line, Aura Biosciences And Other Big Stocks Moving Lower In Monday's Pre-Market Session
benzinga.com
Norwegian Cruise Line, Aura Biosciences And Other Big Stocks Moving Lower In Monday's Pre-Market Ses

US stock futures lower, Dow futures down 200 points. Norwegian Cruise Line shares fall after Q1 resu

Earnings Scheduled For May 4, 2026
benzinga.com
Earnings Scheduled For May 4, 2026

Why eBay Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why eBay Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket

eBay (NASDAQ: EBAY) rose sharply after GameStop (NYSE: GME) proposed to acquire it for $125/share, v

Evolus Targets Double-Digit Growth, Full-Year Profitability at Needham Healthcare Conference
defenseworld.net
Evolus Targets Double-Digit Growth, Full-Year Profitability at Needham Healthcare Conference

Evolus (NASDAQ: EOLS) executives told investors at Needham and Company's 25th Annual Healthcare Conf

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Earnings Scheduled For March 3, 2026
benzinga.com
Earnings Scheduled For March 3, 2026

Alphabet To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday
benzinga.com
Alphabet To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday

benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session

Earnings Scheduled For November 5, 2025
benzinga.com
Earnings Scheduled For November 5, 2025

benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

Super Micro Computer Posts Downbeat Q4 Results, Joins Personalis, Snap And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
benzinga.com
Super Micro Computer Posts Downbeat Q4 Results, Joins Personalis, Snap And Other Big Stocks Moving L

benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Why Astera Labs Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Astera Labs Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket

benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

benzinga.com
Earnings Scheduled For August 5, 2025

benzinga.com
Earnings Scheduled For May 7, 2025

This Twin Disc Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
benzinga.com
This Twin Disc Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

benzinga.com
Earnings Scheduled For March 4, 2025

benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

benzinga.com
Earnings Scheduled For March 7, 2024

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earning

benzinga.com
Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's M

Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA) fell sharply during Monday’s session after the c

benzinga.com
SoFi Technologies Posts Q4 Earnings, Joins Cardlytics, McGrath RentCorp And Other Big Stocks Moving

U.S. stocks traded mixed, with the Dow Jones trading slightly lower on Monday. Shares of SoFi Tech

benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session